Aclarion ACON 深 沪
已收盘 08-07 16:00:00 美东时间
2.29
-0.080
-3.38%
华盛通- 最 高2.50
- 今 开2.29
- 成交量 5.81万股
- 最 低 2.23
- 昨 收 2.37
- 总市值 1644.38万
- 52周最高 12.03
- 市盈率 静 --
- 换手率 0.81%
- 52周最低 1.95
- 委 比 -8.68%
- 总股本 718.07万
- 历史最高 15.08
- 量 比 1.53
- 振 幅 11.39%
- 历史最低 0.0281
- 每 手 1
- 风险率 2.13%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Aclarion Launches Market Access Program In Partnership With PRIA Healthcare
Partnership supports reimbursement strategy and U.S. commercial expansion for Aclarion's AI-driven platform for chronic low back pain.Program aims to follow successful reimbursement wins in the UK that are translating
06-09 19:04
Aclarion Partners With Institute of Neuro Innovation on Back Pain Technology
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms through
06-03 18:09
SentinelOne To Rally Nearly 40%? Here Are 10 Analyst Forecasts For Friday
Top Wall Street analysts changed outlook on top names. For full changes, see analyst ratings page. Stock targets and ratings also updated.
05-29 20:33
Aclarion Adds Lanman Spinal Neurosurgery As Clinical Site In CLARITY Trial
Lanman Spinal Neurosurgery is a leading spine-focused private practice recognized for its expertise in complex spinal procedures, early adoption of innovative technologies and high surgical volumeThe CLARITY randomized
05-07 18:09
Aclarion Announces $2.5M Buyback Plan
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms through its
04-22 20:31
Aclarion Raises $10.4 Million, Sharpens Focus On Nociscan Rollout
Aclarion, Inc. (NASDAQ: ACON) closed a $10.4 million financing at $5.18/share, boosting balance sheet & extending cash runway to 2028.
01-13 23:51
Aclarion Raises $10.4M, Extends Cash Runway Into 2028
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help
01-13 19:01
Is the Market Bullish or Bearish on Aclarion Inc?
Aclarion Inc's (NYSE:ACON) short interest as a percent of float has risen 142.8...
01-10 02:00
Dow Edges Higher; US Economy Adds 50,000 Jobs In December
U.S. stocks traded higher this morning, with the Dow Jones index gaining around...
01-09 23:25
Market-Moving News for January 8th
ACON: 54% | Aclarion Reports Triple-Digit Growth for AI Back Pain Platform as Nociscan Adoption Accelerates ACRV: 38% | Acrivon Therapeutics Announces Update On ACR-368 Program, Reports Initial Clinical
01-08 20:35
